Amneal Pharmaceuticals Inc Class A (AMRX)
SG&A Expense Growth
7.10%
Quarterly · Period ending:
AMRX SG&A Expense Growth
Latest reported7.10%period ending
Latest reported7.10%period ending
AMRX Quarterly SG&A Growth (QoQ) (0.00% → 7.10%)
Latest values, visible window
High-resolution chart · PNG
AMRX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 7.1021% | |
| -5.1878% | |
| 6.2715% | |
| 10.9032% | |
| 5.0538% | |
| -8.0808% | |
| 8.421% | |
| 1.9148% | |
| 3.4344% | |
| 3.2953% | |
| -3.5423% | |
| 7.0437% | |
| 3.4027% | |
| -0.0607% | |
| 2.0855% | |
| 1.2803% | |
| 0.1429% | |
| 1.4821% | |
| 6.3755% | |
| 6.0819% | |
| -5.036% | |
| 7.131% | |
| 1.8852% | |
| 2.6883% | |
| 3.8063% | |
| 5.2535% | |
| 16.1246% | |
| -5.1783% | |
| -20.3172% | |
| 18.53% | |
| -8.7595% | |
| 47.303% | |
| 110.9908% | |
| -6.8419% | |
| -1.7274% | |
| 1.8635% | |
| -2.7579% | |
| -11.0004% | |
| 0% |